![Pascal Neuville](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Neuville
Gründer bei
Peptimimesis SAS
Profil
Pascal Neuville is the founder of Domain Therapeutics SA, founded in 2001, and Peptimimesis SAS, founded in 2015, where the title held is Chairman.
Current jobs include Chairman at Axilum Robotics SAS, Director at Mavalon Therapeutics Ltd. since 2018, and Director at Find Therapeutics.
Former jobs include Head-Research & Development Project at Transgene SA from 2008 to 2008, Professor at the University of Geneva, and President of Alsace BioValley Association from 2009 to 2010.
Education includes a doctorate from the University of Strasbourg.
Aktive Positionen von Pascal Neuville
| Unternehmen | Position | Beginn |
|---|---|---|
Axilum Robotics SAS
 Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures | Vorsitzender | - |
Peptimimesis SAS
 Peptimimesis SAS BiotechnologyHealth Technology Provides biotechnology research services | Gründer | 01.10.2015 |
Find Therapeutics
 Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases | Direktor/Vorstandsmitglied | - |
Mavalon Therapeutics Ltd.
 Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients | Direktor/Vorstandsmitglied | 01.07.2018 |
Ehemalige bekannte Positionen von Pascal Neuville
| Unternehmen | Position | Ende |
|---|---|---|
Alsace BioValley Association
 Alsace BioValley Association Medical/Nursing ServicesHealth Services Operates as health innovation center | Präsident | 01.01.2010 |
| TRANSGENE | Corporate Officer/Principal | 01.01.2008 |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Gründer | - |
Ausbildung von Pascal Neuville
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alsace BioValley Association
Alsace BioValley Association Medical/Nursing ServicesHealth Services Operates as health innovation center | Health Services |
Axilum Robotics SAS
Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures | Commercial Services |
Peptimimesis SAS
Peptimimesis SAS BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Mavalon Therapeutics Ltd.
Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients | Health Technology |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases | Health Technology |
Wählen Sie MarketScreener 
